Moreno, C., Montillo, M., Panayiotidis, P., Dimou, M., Bloor, A., Dupuis, J., Schuh, A., Norin, S., Geisler, C., Hillmen, P., Doubek, M., Trněný, M., Obrtlikova, P., Laurenti, L., Stilgenbauer, S., Smolej, L., Ghia, P., Cymbalista, F., Jaeger, U., Stamatopoulos, K., Stavroyianni, N., Carrington, P., Zouabi, H., Leblond, V., Gomez-Garcia, J. C., Rubio, M., Marasca, R., Musuraca, G., Rigacci, L., Farina, L., Paolini, R., Pospisilova, S., Kimby, E., Bradley, C. and Montserrat, E. (2015) “Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia”, Haematologica. Pavia, Italy, 100(4), pp. 511-516. doi: 10.3324/haematol.2014.118158.